FluoGuide A/S
Develops fluorescent drugs to guide surgeons for more precise cancer removal and patient outcomes.
FLUO | ST
Overview
Corporate Details
- ISIN(s):
- DK0061123312
- LEI:
- 89450078OGAJQ84J9R62
- Country:
- Denmark
- Address:
- Ole Maaløes Vej 3, 2200 København N
- Website:
- https://fluoguide.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
FluoGuide A/S is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through precision surgery. The company develops drugs that make cancer cells fluorescent during surgical procedures. Its lead product, FG001, is designed to 'light up' cancer, enabling surgeons to more accurately distinguish and remove malignant tissue while preserving healthy surrounding tissue. By enhancing surgical precision, FluoGuide aims to reduce the rate of cancer recurrence, minimize complications, and lower overall healthcare costs associated with readmissions and further treatments. The company's technology is based on a proprietary uPAR-targeted platform and is currently being evaluated in clinical trials for various types of cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all FluoGuide A/S filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for FluoGuide A/S via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
